Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bruker Corp
(NQ:
BRKR
)
57.73
-2.76 (-4.56%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bruker Corp
< Previous
1
2
3
Next >
Bruker Analysts Cut Their Forecasts After Q3 Results
November 06, 2024
Via
Benzinga
Decoding 3 Analyst Evaluations For Bruker
November 06, 2024
Via
Benzinga
A Look Ahead: Bruker's Earnings Forecast
November 04, 2024
Via
Benzinga
Analyst Scoreboard: 4 Ratings For Bruker
September 30, 2024
Via
Benzinga
BRKR Stock Earnings: Bruker Misses EPS, Beats Revenue for Q2 2024
August 06, 2024
BRKR stock results show that Bruker missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
7 Quantum Computing Stocks That Could Be Multibaggers in the Making: July Edition
July 17, 2024
Explore quantum computing stocks with potential to become multibaggers as the industry advances and commercializes across various sectors.
Via
InvestorPlace
Rags to Riches: 3 Nanotech Stocks That Could Make Early Investors Rich
June 26, 2024
Seemingly everyone wants to think big. With nanotech stocks to buy, it’s all about thinking small in a gargantuan way.
Via
InvestorPlace
Peeling Back The Layers: Exploring Bruker Through Analyst Insights
May 20, 2024
Via
Benzinga
Unveiling 4 Analyst Insights On Bruker
February 14, 2024
Via
Benzinga
Earnings Outlook For Bruker
February 12, 2024
Via
Benzinga
Why Bruker (BRKR) Shares Are Falling During Thursday's Session
May 30, 2024
Bruker shares are trading lower by 6.6% during Thursday's session. The company announced a public offering of 6 million shares of its common stock.
Via
Benzinga
Shhh! 3 Secret Nanotech Stocks Flying Below Wall Street’s Radar
May 10, 2024
You might want to get in on these three under-the-radar nanotech stocks before Wall Street catches on to the technology's potential.
Via
InvestorPlace
Last Week's Worst-Performing Stocks: Are These 15 Large-Cap Stocks In Your Portfolio? (April 28-May 4, 2024)
May 05, 2024
15 large-cap stocks had a rough week, with CVS, Starbucks, and DoorDash all taking major hits. Analysts have lowered price targets on many.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
May 02, 2024
Via
Benzinga
Earnings Outlook For Bruker
November 01, 2023
Via
Benzinga
Bruker: Dividend Insights
October 31, 2023
Via
Benzinga
Health Care Company Bruker Announces Acquisition of PhenomeX
August 17, 2023
Via
Benzinga
BRKR Stock Earnings: Bruker Beats EPS, Misses Revenue for Q1 2024
May 02, 2024
BRKR stock results show that Bruker beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Last Week's Worst-Performing Stocks: Are These 11 Large-Cap Stocks In Your Portfolio?
April 21, 2024
Last week's worst performers included Arm Holdings, Coinbase Global, Live Nation Entertainment and J.B. Hunt Transport Services.
Via
Benzinga
Shockwave Medical Stock Sees Relative Strength Rating Ride Higher
March 27, 2024
On Wednesday, Shockwave Medical stock got a positive adjustment to its Relative Strength (RS) Rating, from 90 to 94.
Via
Investor's Business Daily
Chart Of The Day: Bruker Measures Up
March 08, 2024
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally.
Via
Talk Markets
The 3 Best Nasdaq Stocks to Buy in February 2024
February 17, 2024
These three Nasdaq stocks to buy now offer solid growth prospects, favorable starting valuations, and some dividend income in one package.
Via
InvestorPlace
UBS Maintains Buy Rating for Bruker: Here's What You Need To Know
February 15, 2024
Via
Benzinga
Citigroup To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Wednesday
February 14, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 13, 2024
Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued soft first-quarter guidance.
Via
Benzinga
Ecolab Posts Strong Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Tuesday
February 13, 2024
U.S. stocks were lower, with the Dow Jones index dipping more than 500 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Bruker Stock Rising, Near Buy Point; Gets Rating Upgrade
January 30, 2024
A Relative Strength Rating upgrade for Bruker stock shows improving technical performance. Will it continue?
Via
Investor's Business Daily
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.
Via
Benzinga
Exposures
COVID-19
Earnings Scheduled For February 13, 2024
February 13, 2024
Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million.
Via
Benzinga
Bruker Enters Functional Single-Cell Biology Research Solutions With PhenomeX Acquisition
August 17, 2023
Bruker Corporation (NASDAQ: BRKR) has agreed to acquire PhenomeX Inc (NASDAQ: CELL) for $1.00 per share in an
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.